Kalciumklorid Abboxia

Calcium, the active ingredient in Kalciumklorid Abboxia, is a calcium supplement presented as an intravenous solution for intravenous use. It treats calcium deficiency and hypocalcemia by rapidly restoring normal serum calcium levels in patients who require prompt correction, including those with acute or chronic calcium depletion due to postoperative states, renal impairment, or endocrine disorders.

GNH USA supplies Kalciumklorid Abboxia as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide, manufactured under EU GMP standards and distributed through a regulated supply chain.

Kalciumklorid Abboxia is used to correct calcium deficits and related metabolic disturbances, supporting essential physiological functions.

- Calcium deficiency: restores normal serum calcium concentrations in patients with inadequate dietary intake, malabsorption syndromes, or chronic losses. - Hypocalcemia: rapidly raises low blood calcium levels in acute settings such as postoperative care, renal failure, or severe vitamin D deficiency. - Bone health maintenance: supplies calcium for bone mineralization and remodeling in individuals at risk of demineralization, such as elderly or osteoporotic patients.

Intravenous calcium can be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Injection site pain: mild discomfort at the infusion site. - Transient hypercalcemia: temporary elevation of serum calcium that resolves without intervention. - Nausea: feeling of sickness or urge to vomit.

Serious or Rare Side Effects: - Severe hypercalcemia: marked elevation of calcium causing cardiac arrhythmias. - Cardiac arrhythmia: irregular heart rhythm potentially life‑threatening. - Renal stone formation: calcium deposits in kidneys leading to obstruction.

When using Kalciumklorid Abboxia, several precautions should be observed to ensure safe administration.

- Assess serum calcium: measure baseline and monitor levels during therapy to avoid overcorrection. - Monitor renal function: ensure kidneys can handle calcium load, especially in patients with renal impairment. - Avoid in hypercalcemia: contraindicated for patients with already elevated calcium concentrations. - Use cautiously in cardiac disease: calcium can affect myocardial contractility and conduction. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Calcium infusion may interact with several medications, requiring attention to avoid adverse effects.

Major Interactions (Avoid): - Digitalis glycosides: increased risk of toxicity due to calcium‑mediated effects on cardiac conduction. - Loop diuretics: may cause excessive calcium loss, necessitating dose adjustment. - Bisphosphonates: concurrent use can blunt the intended rise in serum calcium.

Moderate Interactions (Monitor Closely): - Thiazide diuretics: may increase calcium levels, requiring monitoring. - Vitamin D supplements: enhance calcium absorption, potentially leading to hypercalcemia. - ACE inhibitors: may affect blood pressure response during calcium infusion.